Many tech companies–Facebook, Samsung, and Google, among others–are interested in the potential of virtual reality and investing heavily in the technology. Now entertainment companies are also staking claims. Disney has apparently led a $65 million round of funding into Jaunt VR, a startup which makes live-action virtual reality content and also offers a camera system for capturing 360-degree live-action videos.
For Disney, the move makes sense. Passive entertainment such as short films is likely to be among the first mass market applications for virtual reality. Jaunt has already made some waves in this area, releasing live-action, immersive films such as one of Sir Paul McCartney playing “Live and Let Die” in concert. Disney’s investment suggests that it thinks that the headsets coming soon from Facebook’s Oculus and its competitors are going to be good enough to become widely popular in the next couple years.
However, I’m guessing Disney is also interested in finding ways to incorporate the kind of content Jaunt makes into its theme parks. Disney has used virtual reality in its theme parks in the past, such as with its DisneyQuest theme park at Disney World in Orlando, Florida, which opened in 1998. It includes experiences like Aladdin’s Magic Carpet Ride, where visitors put on a virtual reality headset and sat on something like a stationary bicyle. But DisneyQuest is looking pretty retro and tired–so much so, in fact, that it’s closing down next year.
If Disney wants to try again with virtual reality, Jaunt might seem like an attractive company to work with. The startup, which was founded in 2013 and is based in Palo Alto, California, says the investment will help it to improve its cameras and production software, as well as add more employees at its home base and a new studio in Los Angeles. Jaunt has now raised over $100 million in funding.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.